» Articles » PMID: 39200332

Variability of Mitochondrial DNA Heteroplasmy: Association with Asymptomatic Carotid Atherosclerosis

Abstract

Atherosclerosis is one of the main reasons for cardiovascular disease development. This study aimed to analyze the association of mtDNA mutations and atherosclerotic plaques in carotid arteries of patients with atherosclerosis and conditionally healthy study participants from the Novosibirsk region. PCR fragments of DNA containing the regions of 10 investigated mtDNA mutations were pyrosequenced. The heteroplasmy levels of mtDNA mutations were analyzed using a quantitative method based on pyrosequencing technology developed by M. A. Sazonova and colleagues. In the analysis of samples of patients with atherosclerotic plaques of the carotid arteries and conditionally healthy study participants from the Novosibirsk region, four proatherogenic mutations in the mitochondrial genome (m.5178C>A, m.652delG, m.12315G>A and m.3256C>T) and three antiatherogenic mutations in mtDNA (m.13513G>A, m.652insG, and m.14846G>A) were detected. A west-east gradient was found in the distribution of the mtDNA mutations m.5178C>A, m.3256C>T, m.652insG, and m.13513G>A. Therefore, four proatherogenic mutations in the mitochondrial genome (m.5178C>A, m.652delG, m.12315G>A, and m.3256C>T) and three antiatherogenic mutations in mtDNA (m.13513G>A, m.652insG, and m.14846G>A) were detected in patients with atherosclerotic plaques in their carotid arteries from the Novosibirsk region.

Citing Articles

The Role of mtDNA Mutations in Atherosclerosis: The Influence of Mitochondrial Dysfunction on Macrophage Polarization.

Fedotova E, Berezhnov A, Popov D, Shitikova E, Vinokurov A Int J Mol Sci. 2025; 26(3).

PMID: 39940788 PMC: 11817597. DOI: 10.3390/ijms26031019.

References
1.
Battle S, Puiu D, Verlouw J, Broer L, Boerwinkle E, Taylor K . A bioinformatics pipeline for estimating mitochondrial DNA copy number and heteroplasmy levels from whole genome sequencing data. NAR Genom Bioinform. 2022; 4(2):lqac034. PMC: 9112767. DOI: 10.1093/nargab/lqac034. View

2.
Lee S, Han J . Mitochondrial Mutations in Cardiac Disorders. Adv Exp Med Biol. 2017; 982:81-111. DOI: 10.1007/978-3-319-55330-6_5. View

3.
Zhang T, Chen J, Tang X, Luo Q, Xu D, Yu B . Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis. Lipids Health Dis. 2019; 18(1):223. PMC: 6913018. DOI: 10.1186/s12944-019-1170-9. View

4.
Zhang H, Zeng Y, Yang H, Hu Y, Hu Y, Chen W . Familial factors, diet, and risk of cardiovascular disease: a cohort analysis of the UK Biobank. Am J Clin Nutr. 2021; 114(5):1837-1846. DOI: 10.1093/ajcn/nqab261. View

5.
Doroschuk N, Postnov A, Doroschuk A, Ryzhkova A, Sinyov V, Sazonova M . An original biomarker for the risk of developing cardiovascular diseases and their complications: Telomere length. Toxicol Rep. 2021; 8:499-504. PMC: 7941069. DOI: 10.1016/j.toxrep.2021.02.024. View